$67.91 -0.09 (-0.13%)

Doximity, Inc. (DOCS)

Doximity, Inc. (DOCS) is a professional networking platform tailored for healthcare professionals, enabling doctors, nurses, and healthcare providers to connect, share information, and collaborate securely. The company offers tools for telehealth, documentation, and professional development, aiming to improve communication and efficiency within the medical community. Founded in 2010, Doximity has become a leading digital platform for healthcare professionals in the United States.

🚫 Doximity, Inc. does not pay dividends

Company News

Doximity (DOCS) Q1 Revenue Rises 15%
The Motley Fool • Jesterai • August 8, 2025

Doximity reported Q1 FY2026 results with revenue of $145.9 million, missing analyst expectations but beating earnings per share estimates. The company raised full-year guidance and showed strong performance in AI tool adoption and workflow solutions.

Doximity, Inc. Long-Term Shareholder Announcement: Johnson Fistel Encourages Investors to Reach Out For More Information About Continuing Investigation
GlobeNewswire Inc. • Johnson Fistel, Pllp • July 9, 2025

Johnson Fistel is investigating potential legal claims against Doximity, alleging securities fraud involving misrepresentation of user metrics and growth prospects. A court recently denied defendants' motion to dismiss the class action lawsuit.

Palantir, Super Micro Computer And Spotify Are Among Top 10 Large Cap Gainers Last Week (Feb 3-Feb 7): Are The Others In Your Portfolio?
Benzinga • Lekha Gupta • February 9, 2025

Several large-cap stocks, including Palantir, Doximity, Super Micro Computer, and Spotify, were among the top performers last week, with gains ranging from 13% to 34%. The strong financial results and analyst upgrades contributed to the stock price increases.

Doximity (DOCS) Ascends While Market Falls: Some Facts to Note
Zacks Investment Research • Zacks Equity Research • June 28, 2024

Doximity (DOCS) closed the most recent trading day at $27.97, moving +0.5% from the previous trading session.

Dr. Martens shares plunge to all-time lows as shoemaker cuts guidance on weak U.S. sales
MarketWatch • MarketWatch • November 30, 2023

Dr. Martens reported a 57% drop in its first-half profits following plunging sales to U.S. wholesalers